Top 5 Drug Type | Count |
---|---|
Cell therapy | 1 |
Biological products | 1 |
Target- |
Mechanism- |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhasePhase 3 |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism Tissue replacements |
Active Org.- |
Originator Org. |
Active Indication- |
Inactive Indication |
Drug Highest PhaseWithdrawn |
First Approval Ctry. / Loc. US |
First Approval Date09 Mar 2012 |
Target- |
Mechanism Cell replacements |
Active Org.- |
Originator Org. |
Active Indication- |
Inactive Indication |
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
Start Date06 Sep 2023 |
Sponsor / Collaborator |
Start Date14 Jun 2021 |
Sponsor / Collaborator |
Start Date14 Dec 2020 |
Sponsor / Collaborator ![]() [+1] |
Drug(Targets) | Indications | Global Highest Phase |
---|---|---|
Allogeneic cultured keratinocytes and fibroblasts in bovine collagen | Gingival Diseases More | Approved |
Amniotic Suspension Allograft(Organogenesis) | Osteoarthritis, Knee More | Phase 3 |
Amniotic cell therapy (NuCel) | Intervertebral Disc Degeneration More | Pending |